Skip to main content
SpringerLink
Log in

Blockade of spatial learning by the M1 muscarinic antagonist pirenzepine

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Two experiments were conducted to determine the effects of the M1 muscarinic receptor antagonist pirenzepine on place navigation in a water maze. In the first experiment rats were required to learn the location of a hidden platform following intracerebroventricular injections of equimolar doses of pirenzepine or scopolamine methylbromide. Both drugs dose-dependently impaired spatial learning according to both escape latency data and transfer test analysis. Pirenzepine was approximately 3 times less potent than scopolamine, a potency ratio which suggests M1 receptor mediation of the impairment. In the second experiment pirenzepine (1∼92.3 μg/rat ICV) was injected prior to training on a simultaneous place dicrimination task in the water maze. Impairments of choice accuracy were found with a dose of 20 μg/rat in the absence of any marked increases in either errors of omission or choice latency. These data suggest that M1 receptor blockade impairs processes which are involved in spatial learning.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Beatty WW, Bierley RA (1985) Scopolamine degrades spatial working memory but spares spatial reference memory: Dissimilarity of anticholinergic effect and restriction of distal visual cues. Pharmacol Biochem Behav 23:1–6

    Google Scholar 

  • Beninger RJ, Jhamandas K, Boegman RJ, El-Drefawy SR (1986) Effects of scopolamine and unilateral lesions of the basal forebrain on T-maze spatial discrimination and alternation in rats. Pharmacol Biochem Behav 24:1353–1360

    Google Scholar 

  • Birdsall NJM, Hulme EC (1976) Biochemical studies on muscarinic acetylcholine receptors. J Neurochem 27:7–16

    Google Scholar 

  • Birdsall NJM, Hulme EC (1983) Muscarinic receptor subclasses. TIPS 4:459–463

    Google Scholar 

  • Buresova O, Bolhuis JJ, Bures J (1986) Differential effects of cholinergic blockade on performance of rats in the water tank navigation task and in a radial water maze. Behav Neurosci 100:476–482

    Google Scholar 

  • Caulfield MP, Higgins GA, Straughan DW (1983) Central administration of the muscarinic receptor subtype-selective antagonist pirenzepine selectively impairs passive avoidance learning in the mouse. J Pharm Pharmacol 35:131–132

    Google Scholar 

  • Collerton D (1986) Cholinergic function and intellectual decline in Alzheimer's disease. Neuroscience 19:1–28

    Google Scholar 

  • Cortes R, Palacios JM (1986) Muscarinic cholinergic receptor subtypes in the rat brain: I Quantitative autoradiographic studies. Brain Res 362:227–238

    Google Scholar 

  • Cortes R, Probst A, Tobler HJ, Palacios JM (1986) Muscarinic cholinergic receptor subtypes in the human brain: II Quantitative autoradiographic studies. Brain Res 362:239–253

    Google Scholar 

  • Eckerman DA, Winford AG, Edwards JD, Macphail RC, Gage MI (1980) Effects of scopolamine, pentobarbital and amphetamine on radial arm maze performance in the rat. Pharmacol Biochem Behav 12:595–602

    Google Scholar 

  • Egan TM, North RA (1985) Acetylcholine acts on M2-muscarinic receptors to excite rat locus coeruleus neurones. Br J Pharmacol 85:733–735

    Google Scholar 

  • Egan TM, North RA (1986) Acetylcholine hyperpolarizes central neurones by acting on an M2 muscarinic receptor. Nature 319:405–407

    Google Scholar 

  • Eglen RM, Whiting RL (1985) Muscarinic receptor subtypes: problems of classification. TIPS 6:357–358

    Google Scholar 

  • Eglen RM, Whiting RL (1986) Muscarinic receptor subtypes: a critique of the current classification and a proposal for a working nomenclature. J Auton Pharmacol 5:323–346

    Google Scholar 

  • Flood JF, Landry DW, Jarvik ME (1981) Cholinergic receptor interactions and their effects on long term memory processing. Brain Res 215:177–185

    Google Scholar 

  • Gold PE, Zornetzer SF (1983) The mnemon and its juices. Neuromodulation of memory processes. Behav Neurol Biol 38:151–189

    Google Scholar 

  • Hagan JJ, Morris RGM (1987) The cholinergic hypothesis of memory: A review of animal experiments. In: Snyder S, Iversen LL, Iversen SD (eds) The handbook of psychopharmacology, vol 6, Plenum, New York (in press)

    Google Scholar 

  • Hagan JJ, Tweedie F, Morris RGM (1986) Lack of task specificity and absence of posttraining effects of atropine on learning. Behav Neurosci 100:483–493

    Google Scholar 

  • Hammer R, Berrie CP, Birdsall NJM, Burgen ASV, Hulme EC (1980) Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature 283:90–91

    Google Scholar 

  • Hammer R, Giachetti A (1982) Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization. Life Sci 31:2991–2998

    Google Scholar 

  • Hepler DJ, Olton DS, Wenk GL, Coyle JT (1985) Lesions in nucleus basalis magnocellularis and media septum area of rats produce qualitatively similar memory impairments. J Neurosci 5:866–873

    Google Scholar 

  • Knowlton BJ, Wenk GL, Olton DS, Coyle JT (1985) Basal forebrain lesions produce a dissociation of trial-independent memory performance. Brain Res 345:315–321

    Google Scholar 

  • Kolb B, Sutherland RJ, Whishaw IQ (1983) A comparison of the contributions of the frontal and parietal association cortex to spatial localisation in rats. Behav Neurosci 97:13–27

    Google Scholar 

  • Lin SC, Olson KA, Okazaki H, Richelson E (1986) Studies on muscarinic binding sites in human brain identified with [3H]pirenzepine. J Neurochem 46:274–279

    Google Scholar 

  • Macht DI (1924) A pharmacological analysis of the cerebral effects of atropine, homatropin, scopolamin and related drugs. J Pharmacol Exp Ther 22:35–48

    Google Scholar 

  • Mash DC, Flynn DA, Potter LT (1985) Loss of M2 muscarinic receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Science 228:1115–1117

    Google Scholar 

  • McCormick DA, Prince DA (1986) Acetylcholine induces burst firing in thalamic reticular neurones by activating a potassium conductance. Nature 319:402–405

    Google Scholar 

  • Messer WS, Hoss WP, Thomas GJ (1985) Intrahippocampal injections of pirenzepine selectively impair representational memory. Soc Neurosci (Abstr) 1:387.6

    Google Scholar 

  • Meyer EM, Otero DH (1985) Pharmacological and ionic characterization of the muscarinic receptors modulating [3H]acetylcholine release from rat cortical synaptosomes. J Neurosci 5:1202–1207

    Google Scholar 

  • Morris RGM, Garrud P, Rawlins JNP, O'Keefe J (1982) Place navigation impaired in rats with hippocampal lesions. Nature 297:681–683

    Google Scholar 

  • Morris RGM, Hagan JJ, Rawlins JNP (1986) Allocentric spatial learning by hippocampectomised rats: A further test of the “spatial mapping” and “working memory” theories of hippocampal function. Q J Exp Psychol [B] 38:365–395

    Google Scholar 

  • North RA, Slack BE, Surprenant A (1985) Muscarinic M1 and M2 receptors mediate depolarization and presynaptic inhibition in guinea-pig enteric nervous system. J Physiol 368:435–452

    Google Scholar 

  • Okaichi H, Jarrard LE (1982) Scopolamine impairs performance of a place and cue task in rats. Behav Neural Biol 35:319–325

    Google Scholar 

  • Perry EK, Tomlinson BE, Blessed G, Bergman K, Gibson PH, Perry RH (1978) Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 2:1457–1459

    Google Scholar 

  • Pontecorvo MJ, Evans HC (1985) Effects of aniracetam on delayed-matching-to sample performance of monkeys and pigeons. Pharmacol Biochem Behav 22:745–752

    Google Scholar 

  • Spencer DG, Horvath E, Traber J (1985) Coupled (high affinity) and uncoupled (low affinity) M2 muscarinic receptor distributions in rat brain are identical but distinct from M1 receptor distributions. Neurosci Lett [Suppl] 22:S182

  • Sutherland RJ, Whishaw IQ, Regehr JC (1982) Cholinergic receptor blockade impairs spatial localization by use of distal cues in the rat. J Comp Physiol Psychol 96:563–573

    Google Scholar 

  • Tonnaer JADM, Van Vugt MA, De Boer Th, De Graaf JS (1987) Differential interaction of muscarinic drugs with binding sites of [3H]pirenzepine and [3H]quinuclidinyl benzilate in rat brain tissue. Life Sci 40:1981–1987

    Google Scholar 

  • Wamsley JK, Gehlert DR, Roeske WR, Yamamura HI (1984) Muscarinic antagonist binding site heterogeneity as evidenced by autoradiography after direct labelling with [3H]QNB and [3H]pirenzepine. Life Sci 34:1395–1402

    Google Scholar 

  • Warburton DM, Brown K (1971) Attenuation of stimulus sensitivity induced by scopolamine. Nature 230:126–127

    Google Scholar 

  • Watson M, Vickroy TW, Roeske WR, Yamamura HI (1985) Functional and biochemical basis for multiple muscarinic acetylcholine receptors. Prog Neuro-Psychopharmacol Biol Psychiatry 9:569–574

    Google Scholar 

  • Watts J, Stevens R, Robinson C (1981) Effects of scopolamine on radial maze performance in rats. Physiol Behav 26:845–851

    Google Scholar 

  • Whishaw IQ (1985) Cholinergic receptor blockade in the rat impairs locale but not taxon strategies for place navigation in a swimming pool. Behav Neurosci 99:979–1005

    Google Scholar 

  • Whishaw IQ, Robinson TE, Schallert T (1976) Intraventricular anticholinergics do not block cholinergic hippocampal RSA or neocortical desynchronization in the rabbit or rat. Pharmacol Biochem Behav 5:275–283

    Google Scholar 

  • Whishaw IQ, O'Connor WT, Dunnett SB (1985) Disruption of central cholinergic systems in the rat by basal forebrain lesions and atropine: Effects on feeding, sensorimotor behavior, locomotor activity and spatial navigation. Behav Brain Res 17:103–115

    Google Scholar 

  • Willner P, Wise D, Ellis T (1986) Specific disruption of spatial behaviour in rats by central muscarinic receptor blockade. Psychopharmacology 90:229–235

    Google Scholar 

  • Winer B (1971) Statistical principles in experimental design. McGraw-Hill Kogakusha

  • Wirsching BA, Beninger RJ, Jhamandas K, Boegman RJ, El-Defrawy SR (1984) Differential effects of scopolamine on working memory and reference memory of rats in the radial maze. Pharmacol Biochem Behav 20:639–662

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Scientific Development Group, Organon International B.V., P.O. Box 20, NL-5340 BH OSS, The Netherlands

    J. J. Hagan, J. H. M. Jansen & C. L. E. Broekkamp

Authors
  1. J. J. Hagan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. H. M. Jansen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. L. E. Broekkamp
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hagan, J.J., Jansen, J.H.M. & Broekkamp, C.L.E. Blockade of spatial learning by the M1 muscarinic antagonist pirenzepine. Psychopharmacology 93, 470–476 (1987). https://doi.org/10.1007/BF00207237

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00207237

Key words

Search

Navigation